Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillermo Horga

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
JAMA Psychiatry|December 27, 2013
Discriminating risk and resilience endophenotypes from lifetime illness effects in familial major depressive disorderBradley S Peterson, Zhishun Wang, Guillermo Horga, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2019
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brainClifford M Cassidy, Fabio A Zucca, Ragy R Girgis, et al.
Psychological Medicine|June 29, 2018
A predictive model for conversion to psychosis in clinical high-risk patientsAdam J Ciarleglio, Gary Brucato, Michael D Masucci, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2025
Associations of neuromelanin in the substantia nigra with antipsychotic response in schizophreniaRyosuke Tarumi, Shiori Honda, Clifford Cassidy, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|June 8, 2025
Auditory and Visual Thalamocortical Connectivity Alterations in Unmedicated People With Schizophrenia: An Individualized Sensory Thalamic Localization and Resting-State Functional Connectivity StudyJohn C Williams, Philip N Tubiolo, Roberto B Gil, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Auditory and Visual Thalamocortical Connectivity Alterations in Unmedicated People with Schizophrenia: An Individualized Sensory Thalamic Localization and Resting-State Functional Connectivity StudyJohn C Williams, Philip N Tubiolo, Roberto B Gil, et al.
Neuroscience Applied|July 14, 2025
Striatal dopamine synthesis capacity and neuromelanin in the substantia nigra: A multimodal imaging study in schizophrenia and healthy controlsCarmen F M van Hooijdonk, Marieke van der Pluijm, Charlotte Smith, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 14, 2020
Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteersJoshua T Kantrowitz, Jack Grinband, Donald C Goff, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Translational Evidence for Dopaminergic Rewiring of the Basal Ganglia in Persons with SchizophreniaPhilip N Tubiolo, John C Williams, Roberto B Gil, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
JAMA Psychiatry|December 27, 2013
Discriminating risk and resilience endophenotypes from lifetime illness effects in familial major depressive disorderBradley S Peterson, Zhishun Wang, Guillermo Horga, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2019
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brainClifford M Cassidy, Fabio A Zucca, Ragy R Girgis, et al.
Psychological Medicine|June 29, 2018
A predictive model for conversion to psychosis in clinical high-risk patientsAdam J Ciarleglio, Gary Brucato, Michael D Masucci, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2025
Associations of neuromelanin in the substantia nigra with antipsychotic response in schizophreniaRyosuke Tarumi, Shiori Honda, Clifford Cassidy, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|June 8, 2025
Auditory and Visual Thalamocortical Connectivity Alterations in Unmedicated People With Schizophrenia: An Individualized Sensory Thalamic Localization and Resting-State Functional Connectivity StudyJohn C Williams, Philip N Tubiolo, Roberto B Gil, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Auditory and Visual Thalamocortical Connectivity Alterations in Unmedicated People with Schizophrenia: An Individualized Sensory Thalamic Localization and Resting-State Functional Connectivity StudyJohn C Williams, Philip N Tubiolo, Roberto B Gil, et al.
Neuroscience Applied|July 14, 2025
Striatal dopamine synthesis capacity and neuromelanin in the substantia nigra: A multimodal imaging study in schizophrenia and healthy controlsCarmen F M van Hooijdonk, Marieke van der Pluijm, Charlotte Smith, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 14, 2020
Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteersJoshua T Kantrowitz, Jack Grinband, Donald C Goff, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Translational Evidence for Dopaminergic Rewiring of the Basal Ganglia in Persons with SchizophreniaPhilip N Tubiolo, John C Williams, Roberto B Gil, et al.
Pageof 10